Ovarian hyperstimulation syndrome

by admin on March 15, 2009

However, the clinical symptoms and evidence of OHSS exhibit a continuum of scope and severity that defies attempts at explicit classification or staging. Onset of symptoms generally happens shortly after ovulation ( in superovulation cycles ) or after oocyte retrieval in ART cycles, but it could be delayed. Progression of sickness is recognized when symptoms endure, worsen, or include ascites that is demonstrated by inflating intestinal girth or ultrasound analysis.

Risk of thromboembolism is increased as a consequence of hemoconcentration, lessened marginal blood flow, and inactivity due to abdominal distension and agony. Withholding further gonadotropin kick and delaying hCG administration till estradiol levels plateau or decrease noticeably can reduce risks of OHSS.

Available evidence proves that such “coasting” does not negatively affect outcome in in vitro fertilization ( IVF ) cycles unless it is lengthened ( three days ).

Given the proof recommending that hCG may play a vital role in the development of OHSS, a lower dose of hCG ( e.g, five thousand IU vs. Otherwise, a GnRH agonist ( e.g, leuprolide 0.51.0 mg SC ) instead of hCG could be used to excite an endogenous LH surge to push last oocyte maturation and prompt ovulation. This approach would be helpful only in cycles not concerning prior down-regulation with long term agonist treatment or use of a GnRH opponent ( e.g, ganirelix, cetrorelix ). When symptoms of OHSS appear even before administration of hCG, cycle cancellation and less assertive kick in a successive cycle should be seriously considered. Though proof suggests that meticulous follicle aspiration will reduce corpus luteum P production, it may not be depended on to stop development or progression of OHSS in ART cycles.

Studies of its efficiency had variable results, and albumin treatment risks exacerbation of ascites, allergic reactions, and pathogen / prion transmission.

Leave a Comment

Previous post:

Next post: